YGEN — Yourgene Health Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- £16.45m
- £31.98m
- £37.56m
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.15 | 8.88 | 16.6 | 18.3 | 37.6 |
Cost of Revenue | |||||
Gross Profit | 3.17 | 4.61 | 10.2 | 11.4 | 21.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14.7 | 13.7 | 19.9 | 30 | 40.1 |
Operating Profit | -8.6 | -4.78 | -3.24 | -11.7 | -2.54 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.54 | 3.39 | -3.38 | -12 | -3.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.48 | 3.39 | -2.43 | -12.2 | -1.92 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.48 | 3.39 | -2.43 | -12.2 | -1.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.48 | 3.39 | -2.43 | -12.2 | -1.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.024 | 0.009 | -0.003 | -0.013 | -0.002 |